News & Events about Amyris Inc.
Key Insights Significantly high institutional ownership implies Amyris' stock prices are sensitive to their trading...
AMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT AMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PR Newswire EMERYVILLE, Calif., Dec. 29, 2022 EMERYVILLE, Calif., Dec. 29, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq...
AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION PR Newswire EMERYVILLE, Calif., Dec. 27, 2022 EMERYVILLE, Calif., Dec. 27, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's...
Thinking about buying stock in Mullen Automotive, Soleno Therapeutics, Agrify, AMC Entertainment, or Amyris? Thinking about buying stock in Mullen Automotive, Soleno Therapeutics, Agrify, AMC Entertainment, or Amyris? PR Newswire NEW YORK, Dec. 19, 2022 NEW YORK, Dec. 19, 2022 /PRNewswire...
AMYRIS CONSUMER BRANDS DELIVER 80% CYBER MONDAY LIKE-FOR-LIKE GROWTH AMYRIS CONSUMER BRANDS DELIVER 80% CYBER MONDAY LIKE-FOR-LIKE GROWTH PR Newswire EMERYVILLE, Calif., Nov. 30, 2022 EMERYVILLE, Calif., Nov. 30, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology...